Rimm DL - Search Results

1

Classification of breast cancer using genetic algorithms and tissue microarrays.

Dolled-Filhart M, Rydén L, Cregger M, Jirström K, Harigopal M, Camp RL, Rimm DL. Dolled-Filhart M, et al. Among authors: rimm dl. Clin Cancer Res. 2006 Nov 1;12(21):6459-68. doi: 10.1158/1078-0432.CCR-06-1383. Clin Cancer Res. 2006. PMID: 17085660

2

Localization and quantitation of expression of the cell motility-related protein thymosin beta15 in human breast tissue.

Gold JS, Bao L, Ghoussoub RA, Zetter BR, Rimm DL. Gold JS, et al. Among authors: rimm dl. Mod Pathol. 1997 Nov;10(11):1106-12. Mod Pathol. 1997. PMID: 9388061

3

Expression of c-met is a strong independent prognostic factor in breast carcinoma.

Ghoussoub RA, Dillon DA, D'Aquila T, Rimm EB, Fearon ER, Rimm DL. Ghoussoub RA, et al. Among authors: rimm eb, rimm dl. Cancer. 1998 Apr 15;82(8):1513-20. doi: 10.1002/(sici)1097-0142(19980415)82:8<1513::aid-cncr13>3.0.co;2-7. Cancer. 1998. PMID: 9554529

4

Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma.

Camp RL, Rimm EB, Rimm DL. Camp RL, et al. Among authors: rimm eb, rimm dl. Cancer. 1999 Dec 1;86(11):2259-65. doi: 10.1002/(sici)1097-0142(19991201)86:11<2259::aid-cncr13>3.0.co;2-2. Cancer. 1999. PMID: 10590366

5

A high number of tumor free axillary lymph nodes from patients with lymph node negative breast carcinoma is associated with poor outcome.

Camp RL, Rimm EB, Rimm DL. Camp RL, et al. Among authors: rimm eb, rimm dl. Cancer. 2000 Jan 1;88(1):108-13. Cancer. 2000. PMID: 10618612

6

Validation of tissue microarray technology in breast carcinoma.

Camp RL, Charette LA, Rimm DL. Camp RL, et al. Among authors: rimm dl. Lab Invest. 2000 Dec;80(12):1943-9. doi: 10.1038/labinvest.3780204. Lab Invest. 2000. PMID: 11140706 Free article.

7

Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis.

Garcia-Rostan G, Camp RL, Herrero A, Carcangiu ML, Rimm DL, Tallini G. Garcia-Rostan G, et al. Among authors: rimm dl. Am J Pathol. 2001 Mar;158(3):987-96. doi: 10.1016/s0002-9440(10)64045-x. Am J Pathol. 2001. PMID: 11238046 Free PMC article.

8

Tissue microarray: a new technology for amplification of tissue resources.

Rimm DL, Camp RL, Charette LA, Costa J, Olsen DA, Reiss M. Rimm DL, et al. Cancer J. 2001 Jan-Feb;7(1):24-31. Cancer J. 2001. PMID: 11269645 Review.

9

Amplification of tissue by construction of tissue microarrays.

Rimm DL, Camp RL, Charette LA, Olsen DA, Provost E. Rimm DL, et al. Exp Mol Pathol. 2001 Jun;70(3):255-64. doi: 10.1006/exmp.2001.2363. Exp Mol Pathol. 2001. PMID: 11418004 Review.

10

Tissue microarray analysis of beta-catenin in colorectal cancer shows nuclear phospho-beta-catenin is associated with a better prognosis.

Chung GG, Provost E, Kielhorn EP, Charette LA, Smith BL, Rimm DL. Chung GG, et al. Among authors: rimm dl. Clin Cancer Res. 2001 Dec;7(12):4013-20. Clin Cancer Res. 2001. PMID: 11751495

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

514 results

Search Page

Filters